OpGen, Inc. (OPGN)
OPGN Stock Price Chart
Explore OpGen, Inc. interactive price chart. Choose custom timeframes to analyze OPGN price movements and trends.
OPGN Company Profile
Discover essential business fundamentals and corporate details for OpGen, Inc. (OPGN) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
5 May 2015
Employees
85.00
Website
https://www.opgen.comCEO
Honjian Tan
Description
OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits. The company's products also comprise ARES Technology Platform, including ARES reference database on antimicrobial resistance using next generation sequencing technology and artificial intelligence powered bioinformatics solutions for antibiotic response prediction; and Unyvero Platform, an automated sample-to-answer molecular diagnostics platform that integrates automated sample preparation, analysis, and identification of disease relevant pathogens and antibiotic resistance markers. The company utilizes molecular diagnostics and informatics to help combat infectious diseases. It also helps clinicians with information about life threatening infections to enhance patient outcomes, and to decrease the spread of infections caused by multidrug-resistant microorganisms. OpGen, Inc. has a collaboration with the New York State Department of Health and ILÚM Health Solutions, LLC to develop a research program to detect, track, and manage antimicrobial-resistant infections at healthcare institutions. The company was incorporated in 2001 and is headquartered in Rockville, Maryland.
OPGN Financial Timeline
Browse a chronological timeline of OpGen, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 Nov 2025
Earnings released on 21 Aug 2025
Earnings released on 5 Jun 2025
Earnings released on 2 Jun 2025
Earnings released on 15 Nov 2024
EPS came in at $1.35 .
Earnings released on 8 Jul 2024
EPS came in at $0.21 surpassing the estimated -$1.90 by +111.05%, while revenue for the quarter reached $28.00K , missing expectations by -97.38%.
Earnings released on 24 Jun 2024
EPS came in at -$2.52 falling short of the estimated -$0.90 by -180.00%, while revenue for the quarter reached $168.15K , missing expectations by -84.29%.
Stock split effective on 20 May 2024
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 27 Mar 2024
EPS came in at -$13.29 falling short of the estimated -$0.13 by -10.12K%, while revenue for the quarter reached $1.07M , beating expectations by +67.14%.
Earnings released on 14 Nov 2023
EPS came in at -$4.60 falling short of the estimated -$4.30 by -6.98%, while revenue for the quarter reached $699.02K , beating expectations by +9.22%.
Earnings released on 10 Aug 2023
EPS came in at -$9.30 falling short of the estimated -$7.10 by -30.99%, while revenue for the quarter reached $736.14K , missing expectations by -18.21%.
Earnings released on 15 May 2023
EPS came in at -$12.50 falling short of the estimated -$1.20 by -941.67%, while revenue for the quarter reached $913.44K , missing expectations by -42.91%.
Earnings released on 29 Mar 2023
EPS came in at -$19.00 falling short of the estimated $2.00 by -1.05K%, while revenue for the quarter reached $721.63K , beating expectations by +20.27%.
Stock split effective on 5 Jan 2023
Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 10 Nov 2022
EPS came in at -$30.00 falling short of the estimated -$2.40 by -1.15K%, while revenue for the quarter reached $448.71K , beating expectations by +12.18%.
Earnings released on 11 Aug 2022
EPS came in at -$26.00 surpassing the estimated -$30.00 by +13.33%, while revenue for the quarter reached $967.21K , missing expectations by -3.28%.
Earnings released on 12 May 2022
EPS came in at -$30.00 surpassing the estimated -$32.00 by +6.25%, while revenue for the quarter reached $469.75K , missing expectations by -55.26%.
Earnings released on 29 Mar 2022
EPS came in at -$70.00 falling short of the estimated -$32.00 by -118.75%, while revenue for the quarter reached $1.43M , beating expectations by +1.83%.
Earnings released on 11 Nov 2021
EPS came in at -$32.00 surpassing the estimated -$38.00 by +15.79%, while revenue for the quarter reached $1.24M , missing expectations by -13.64%.
Earnings released on 12 Aug 2021
EPS came in at -$38.00 matching the estimated -$38.00, while revenue for the quarter reached $811.62K , missing expectations by -27.53%.
Earnings released on 13 May 2021
EPS came in at -$58.00 falling short of the estimated -$44.00 by -31.82%, while revenue for the quarter reached $829.72K , missing expectations by -37.62%.
Earnings released on 25 Mar 2021
EPS came in at -$70.00 falling short of the estimated -$58.00 by -20.69%, while revenue for the quarter reached $1.35M .
Earnings released on 11 Nov 2020
EPS came in at -$80.00 falling short of the estimated -$66.00 by -21.21%, while revenue for the quarter reached $1.06M , beating expectations by +12.50%.
OPGN Stock Performance
Access detailed OPGN performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.